Maria Luisa Biondi

Circa Diatech Pharmacogenetics

Questo autore non ha riempito alcun dettaglio.
Finora Diatech Pharmacogenetics ha creato 1081 post nel blog.

7 03, 2017

Andrea Imperatori et al., LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer. Lung Cancer Journal

Diatech Pharmacogenetics2017-08-03T13:57:48+02:00

1 03, 2017

Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix.

Diatech Pharmacogenetics2017-11-02T13:03:08+01:00

22 02, 2017

Alessia Nottegar et al., Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis. Experimental and Molecular Pathology

Diatech Pharmacogenetics2017-08-03T16:00:36+02:00

31 01, 2017

Daniela Furlan et al., Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis. British Journal of Cancer

Diatech Pharmacogenetics2017-08-08T12:54:16+02:00

27 01, 2017

Myriapod: Terapia personalizzata per la lotta contro il tumore

Diatech Pharmacogenetics2017-08-23T09:55:10+02:00

25 01, 2017

After The Next: Hyb & Seq Technology Nanostring

Diatech Pharmacogenetics2017-08-21T09:39:17+02:00

23 01, 2017

Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix. Oncology Letters

Diatech Pharmacogenetics2017-08-25T09:47:32+02:00

21 01, 2017

Egesta Lopci et al., Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. European Journal of Nuclear Medicine and Molecular Imaging

Diatech Pharmacogenetics2017-08-03T16:49:54+02:00

1 01, 2017

Elisabetta Macerola et al., BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report. International Journal of Surgical Pathology

Diatech Pharmacogenetics2017-08-03T16:59:54+02:00

23 12, 2016

Luca Reggiani Bonetti et al., Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer

Diatech Pharmacogenetics2017-11-02T13:28:53+01:00

Precedente 313233 Successivo